Gene · 6009
Papers4,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the regulatory mechanisms of mTOR in necroptosis. | Front Immunol | 2023 | 38164133 | PubTator, text mining | PubMed |
| ATP-induced cell death: a novel hypothesis for osteoporosis. | Front Cell Dev Biol | 2023 | 38161333 | PubTator, text mining | PubMed |
| Identification of the role of autophagy-related TNFSF10/ hsa-let-7a-5p axis in vitiligo development and potential herbs exploring based on a bioinformatics analysis. | Heliyon | 2023 | 38149194 | PubTator, text mining | PubMed |
| Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma. | Int J Mol Sci | 2023 | 38139462 | PubTator, text mining | PubMed |
| The Evolving Landscape of Therapeutics for Epilepsy in Tuberous Sclerosis Complex. | Biomedicines | 2023 | 38137462 | PubTator, text mining | PubMed |
| NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling. | Cell Biosci | 2023 | 38135881 | PubTator, text mining | PubMed |
| Therapeutic Consequences of Targeting the IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia: A Narrative Review. | Cells | 2023 | 38132107 | PubTator, text mining | PubMed |
| Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications. | Front Pharmacol | 2023 | 38130408 | PubTator, text mining | PubMed |
| VWCE modulates amino acid-dependent mTOR signaling and coordinates with KICSTOR to recruit GATOR1 to the lysosomes. | Nat Commun | 2023 | 38123554 | PubTator, text mining | PubMed |
| S-Nitrosylation-mediated coupling of DJ-1 with PTEN induces PI3K/AKT/mTOR pathway-dependent keloid formation. | Burns Trauma | 2023 | 38116467 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer. | J Exp Clin Cancer Res | 2023 | 38102637 | PubTator, text mining | PubMed |
| The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis. | J Inflamm Res | 2023 | 38088943 | PubTator, text mining | PubMed |
| Genome-wide CRISPR/Cas9 screening for drug resistance in tumors. | Front Pharmacol | 2023 | 38084101 | PubTator, text mining | PubMed |
| DRP1: At the Crossroads of Dysregulated Mitochondrial Dynamics and Altered Cell Signaling in Cancer Cells. | ACS Omega | 2023 | 38075775 | PubTator, text mining | PubMed |
| FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2. | Sci Rep | 2023 | 38065968 | PubTator, text mining | PubMed |
| Transcription Factor EB-Mediated Lysosomal Function Regulation for Determining Stem Cell Fate under Metabolic Stress. | Mol Cells | 2023 | 38052487 | PubTator, text mining | PubMed |
| Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 38050240 | PubTator, text mining | PubMed |
| Research progress in the role and mechanism of Leucine in regulating animal growth and development. | Front Physiol | 2023 | 38046946 | PubTator, text mining | PubMed |
| Communications to the International Sarcopenia Translational Research Conference 2023. | J Frailty Sarcopenia Falls | 2023 | 38046440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6009/papers?page=9